https://www.jazzpharma.com/daily1.0 https://www.jazzpharma.com/comp_announcements/jazz-pharmaceuticals-debuts-catnaptm-pediatric-narcolepsy-registry2023-11-30T09:44Znever https://www.jazzpharma.com/comp_announcements/why-were-acting-renewed-urgency-world-lung-cancer-day-year2023-11-30T12:43Znever https://www.jazzpharma.com/comp_announcements/transforming-together-what-our-recent-acquisition-means-patients-and-our-people2023-11-30T13:03Znever https://www.jazzpharma.com/comp_announcements/small-cell-lung-cancer-nothing-small-about-jazz-and-its-collaborators2025-05-08T20:37Zyearly https://www.jazzpharma.com/comp_announcements/i-have-ih-campaign-reveals-patient-and-supporter-perspectives2024-04-03T08:57Znever https://www.jazzpharma.com/comp_announcements/i-have-ih-campaign-reveals-patient-and-supporter-perspectives-on-the-impact-of-idiopathic-hypersomnia2024-05-17T08:02Zyearly https://www.jazzpharma.com/comp_announcements/pioneering-pathways-trailblazing-new-approaches-in-idiopathic-hypersomnia-and-beyond2024-05-14T08:06Zyearly https://www.jazzpharma.com/comp_announcements/covid-19-response2023-11-30T06:42Znever https://www.jazzpharma.com/perspectives/kicking-2021-jp-morgan-39th-annual-healthcare-conference2023-12-01T09:10Znever https://www.jazzpharma.com/perspectives/innovating-transform-lives-those-sleep-disorders2023-12-01T19:12Znever https://www.jazzpharma.com/perspectives/international-womens-day-what-equality-will-look-after-covid-192025-01-16T20:58Zyearly https://www.jazzpharma.com/perspectives/taking-steps-toward-heart-health-narcolepsy2023-12-01T19:46Znever https://www.jazzpharma.com/perspectives/showcasing-jazzs-commitment-epilepsy-community2023-12-01T20:51Znever https://www.jazzpharma.com/perspectives/elevating-caregivers-voice-people-living-severe-epilepsy-jazz-aes-20222023-12-01T21:14Znever https://www.jazzpharma.com/perspectives/prioritizing-safety-sleep-community2023-12-01T21:16Znever https://www.jazzpharma.com/perspectives/addressing-difficult-treat-cancers-through-patient-centric-lens2023-12-01T21:18Znever https://www.jazzpharma.com/perspectives/driving-innovation-oncology-sleep-jazz-asco-sleep-20232023-12-01T21:20Znever https://www.jazzpharma.com/perspectives/revolutionizing-sleep-nearly-two-decades-dedicated-service-sleep-community2023-12-01T21:31Znever https://www.jazzpharma.com/perspectives/spotlighting-jazzs-commitment-sleep-community-sleep-20232023-12-04T09:14Znever https://www.jazzpharma.com/perspectives/looking-beyond-sleep-take-holistic-approach-patient-well-being2023-12-04T09:16Znever https://www.jazzpharma.com/perspectives/shining-light-on-a-traditionally-overlooked-pharmaceutical-function2024-05-14T08:20Zyearly https://www.jazzpharma.com/perspectives/importance-quantitative-drug-development2023-12-04T09:21Znever https://www.jazzpharma.com/perspectives/advancing-innovation-her2-positive-breast-cancer-jazzs-research-sabcs-20232024-03-29T09:08Znever https://www.jazzpharma.com/perspectives/highlighting-jazzs-commitment-to-the-biliary-tract-cancer-community2024-11-11T21:02Zyearly https://www.jazzpharma.com/perspectives/a-commitment-to-advancing-science-for-biliary-tract-cancer-patients2024-11-11T21:10Zyearly https://www.jazzpharma.com/perspectives/importance-establishing-consensus-treatment-recommendations-rare-epilepsies2024-07-29T20:06Zyearly https://www.jazzpharma.com/perspectives/differentiating-jazzs-rd-expertise-through-quantitative-drug-development2024-09-03T19:56Zyearly https://www.jazzpharma.com/perspectives/celebrate-diversity-month-reflecting-on-personal-and-professional-commitments-to-diversity-equity-and-inclusion2024-05-14T08:21Zyearly https://www.jazzpharma.com/perspectives/power-real-world-evidence-rare-and-difficult-treat-epilepsies2024-09-05T20:11Zyearly https://www.jazzpharma.com/perspectives/sam-pearce-cco-100-day-reflections2025-01-09T20:39Zyearly https://www.jazzpharma.com/perspectives/fueling-innovation-through-jazz-remix-and-employee-experience2025-01-16T21:17Zyearly https://www.jazzpharma.com/perspectives/innovating-care-sleep-conditions-focused-lived-experiences2025-03-20T20:02Zyearly https://www.jazzpharma.com/perspectives/redefining-whats-possible-small-cell-lung-cancer-care2025-10-02T22:43Zyearly https://www.jazzpharma.com/perspectives/embracing-power-patient-experiences-inform-critical-new-data2025-06-03T21:00Zyearly https://www.jazzpharma.com/perspectives/moving-needle-first-line-maintenance-therapy-small-cell-lung-cancer-care2025-10-02T22:42Zyearly https://www.jazzpharma.com/perspectives/reaffirming-our-commitment-epilepsy-community2025-11-18T23:47Zyearly https://www.jazzpharma.com/perspectives/why-innovation-matters-first-line-her2-positive-gastroesophageal-adenocarcinoma2026-01-08T00:19Zyearly https://www.jazzpharma.com/perspectives/sharpening-our-strategic-focus-deepening-our-commitment-rare-disease2026-02-26T22:52Zmonthly https://www.jazzpharma.com/perspectives/celebrating-asian-and-pacific-islander-heritage-month2023-12-01T11:22Znever https://www.jazzpharma.com/perspectives/partners-progress-elevating-sleep-community2026-04-01T18:31Zdaily https://www.jazzpharma.com/perspectives/new-chapter-diffuse-midline-glioma-science-courage-and-power-one-insight2026-04-01T23:01Zdaily https://www.jazzpharma.com/perspectives/celebrating-pride-jazz2023-12-01T13:54Znever https://www.jazzpharma.com/perspectives/leveraging-power-partnerships-impact-lives-small-cell-lung-cancer2023-12-01T15:15Znever https://www.jazzpharma.com/perspectives/partnering-with-stand-up-to-cancer-to-accelerate-research-in-hard-to-treat-cancers-address-disparities-in-access-to-treatments2024-05-14T08:14Zyearly https://www.jazzpharma.com/perspectives/international-lgs-awareness-day-raising-awareness-through-caregivers-journey2023-12-01T15:19Znever https://www.jazzpharma.com/perspectives/launching-first-fda-approved-treatment-ih2023-12-01T15:26Znever https://www.jazzpharma.com/perspectives/recommitting-our-purpose-during-sleep-awareness-month2023-12-01T11:01Znever https://www.jazzpharma.com/perspectives/jazz-musics-inspiring-lessons-effective-leadership2023-12-01T16:20Znever https://www.jazzpharma.com/perspectives/leading-positive-career-development-through-allyship2023-12-01T16:24Znever https://www.jazzpharma.com/perspectives/reflecting-year-transformation2023-12-01T16:26Znever https://www.jazzpharma.com/perspectives/advancing-our-research-development-strategy-begins-patient2023-12-01T16:28Znever https://www.jazzpharma.com/perspectives/discussing-importance-lowering-sodium-narcolepsy-patients2023-12-01T16:53Znever https://www.jazzpharma.com/perspectives/read-about-how-jazz-celebrated-womens-history-month2023-12-01T21:37Znever https://www.jazzpharma.com/patient_stories/normans-story2024-03-29T08:22Znever https://www.jazzpharma.com/patient_stories/meaghans-story2023-12-04T13:51Znever https://www.jazzpharma.com/patient_stories/steve-and-crystals-story2023-12-04T13:55Znever https://www.jazzpharma.com/patient_stories/marks-story2023-12-04T13:58Znever https://www.jazzpharma.com/patient_stories/marys-story-providing-long-term-care-loved-one2024-10-30T08:50Zyearly https://www.jazzpharma.com/patient_stories/shining-light-importance-caregiving2024-09-20T19:25Zyearly https://www.jazzpharma.com/patient_stories/willows-story2024-11-12T21:49Zyearly https://www.jazzpharma.com/patient_stories/supporting-biliary-tract-cancer-patients-through-advocacy-partnerships2024-11-12T21:49Zyearly https://www.jazzpharma.com/patient_stories/eds-story2024-11-12T21:57Zyearly https://www.jazzpharma.com/patient_stories/breast-cancer-rachaels-journey2025-02-04T13:00Zyearly https://www.jazzpharma.com/patient_stories/sams-story2026-02-18T21:18Zmonthly https://www.jazzpharma.com/patient_stories/jesses-acute-lymphoblastic-leukemia-cancer-battle2025-02-08T06:51Zyearly https://www.jazzpharma.com/patient_stories/navigating-life-epilepsy-megann-story2025-02-08T06:56Zyearly https://www.jazzpharma.com/patient_stories/empowering-patients-tools-meaningful-care-team-dialogues-small-cell-lung-cancer2025-11-13T21:42Zyearly https://www.jazzpharma.com/patient_stories/jaces-story2025-11-13T21:43Zyearly https://www.jazzpharma.com/patient_stories/armandos-story2026-02-27T21:40Zmonthly https://www.jazzpharma.com/science_stories/innovation-performs2023-12-04T11:44Znever https://www.jazzpharma.com/science_stories/turning-point-h3-k27m-mutant-diffuse-midline-glioma2025-08-06T19:30Zyearly https://www.jazzpharma.com/science_stories/role-molecular-testing-h3-k27m-mutant-diffuse-midline-glioma-management2025-08-06T19:31Zyearly https://www.jazzpharma.com/science_stories/what-cataplexy2023-12-04T12:10Znever https://www.jazzpharma.com/science_stories/understanding-connection-between-sleep-heart-health-and-sodium-intake2025-09-11T22:37Zyearly https://www.jazzpharma.com/science_stories/advancing-understanding-maintenance-therapy-extensive-stage-small-cell-lung-cancer2025-11-18T23:44Zyearly https://www.jazzpharma.com/science_stories/what-hepatic-veno-occlusive-disease-vod2023-12-04T11:54Znever https://www.jazzpharma.com/science_stories/how-stem-cell-transplantation-can-improve-outcomes-patients-blood-cancers2023-12-04T11:59Znever https://www.jazzpharma.com/science_stories/understanding-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma2023-12-04T12:05Znever https://www.jazzpharma.com/science_stories/showcasing-partnerships-small-cell-lung-cancer2023-12-04T12:09Znever https://www.jazzpharma.com/science_stories/what-if-we-could-pinpoint-biomarkers-to-detect-deadly-transplant-complications-before-symptoms-occur2024-05-14T08:11Zyearly https://www.jazzpharma.com/science_stories/idiopathic-hypersomnia-understanding-often-overlooked-sleep-disorder2023-12-04T12:17Znever https://www.jazzpharma.com/science_stories/understanding-rare-forms-epilepsy2023-12-04T12:23Znever https://www.jazzpharma.com/science_stories/exploring-cardiovascular-burden-narcolepsy2023-12-04T12:28Znever https://www.jazzpharma.com/science_stories/understanding-dravet-syndrome2023-12-04T12:36Znever https://www.jazzpharma.com/science_stories/secondary-aml2023-12-04T11:51Znever https://www.jazzpharma.com/science_stories/exploring-new-treatment-pathways-post-traumatic-stress-disorder2023-12-04T12:39Znever https://www.jazzpharma.com/science_stories/evaluating-new-potential-treatment-essential-tremor2024-03-28T17:51Znever https://www.jazzpharma.com/science_stories/patient-survey-explores-real-world-burden-idiopathic-hypersomnia2024-05-24T14:20Zyearly https://www.jazzpharma.com/science_stories/advancements-in-her2-targeted-cancer-treatments-the-potential-of-bispecific-antibodies2024-05-24T19:40Zyearly https://www.jazzpharma.com/science_stories/potential-her2-targeted-therapies-gastroesophageal-adenocarcinoma2024-06-05T20:02Zyearly https://www.jazzpharma.com/science_stories/experts-raise-awareness-cardiovascular-comorbidities-associated-narcolepsy2024-10-26T07:05Zyearly https://www.jazzpharma.com/science_stories/addressing-patient-priorities-through-sleep-research2025-12-16T21:46Zyearly https://www.jazzpharma.com/science_stories/importance-first-line-maintenance-therapy-small-cell-lung-cancer2025-05-27T20:48Zyearly https://www.jazzpharma.com/science/clinical-trials/HERIZON-GEA-012024-05-21T12:27Zyearly https://www.jazzpharma.com/about/global-footprint/uk-and-ireland2025-07-02T22:51Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-italy-20232024-06-25T21:47Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-luxembourg-20232024-06-26T20:35Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-poland-20232024-06-27T15:54Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-austria-20232024-06-27T15:58Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-finland-20232024-06-27T16:00Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-germany-20232024-06-27T16:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-norway-20232024-06-27T16:16Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-spain-20232025-04-07T08:46Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-sweden-20232025-04-07T08:48Zyearly https://www.jazzpharma.com/about/global-footprint/united-states2025-07-01T23:35Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodology-for-disclosure-switzerland-20232024-06-27T16:32Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-europe-20222024-06-27T16:36Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-europe-20232024-06-27T16:37Zyearly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary/herizon-btc-012024-08-29T19:52Zyearly https://www.jazzpharma.com/advancing-science-her2-positive-cancers2024-11-11T20:50Zyearly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary/study-1-narcolepsy-with-cataplexy2025-06-05T20:23Zyearly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary/study-2-idiopathic-hypersomnia2025-06-05T20:23Zyearly https://www.jazzpharma.com/about/global-footprint/austria2025-11-25T21:13Zyearly https://www.jazzpharma.com/PioneeringPathways2026-03-31T18:42Zweekly https://www.jazzpharma.com/about/global-footprint/switzerland2025-11-25T21:15Zyearly https://www.jazzpharma.com/advancing-care-in-rare-disease2026-02-27T21:41Zmonthly https://www.jazzpharma.com/company-news2024-05-11T13:14Zyearly https://www.jazzpharma.com/contact2026-03-17T20:39Zmonthly https://www.jazzpharma.com/cookie-policy2025-10-28T20:25Zyearly https://www.jazzpharma.com/coupa-supplier-experience2024-05-11T13:14Zyearly https://www.jazzpharma.com/forward-looking-statements2025-05-20T20:00Zyearly https://www.jazzpharma.com/jazz-at-world-sleep-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/us-residents-only2024-05-11T13:14Zyearly https://www.jazzpharma.com/eur-int-residents-only2024-05-11T13:14Zyearly https://www.jazzpharma.com/about2026-02-11T00:25Zmonthly https://www.jazzpharma.com/perspectives2024-05-11T13:14Zyearly https://www.jazzpharma.com/media-alerts2024-05-11T13:14Zyearly https://www.jazzpharma.com/medicines2025-08-06T19:37Zyearly https://www.jazzpharma.com/medicines/drug-safety2026-01-27T19:03Zyearly https://www.jazzpharma.com/medicines/manufacturing2026-03-09T20:12Zmonthly https://www.jazzpharma.com/medicines/manufacturing/athlone-ireland-jazz-pharmaceuticals-ireland-limited2024-05-11T13:14Zyearly https://www.jazzpharma.com/medicines/medical-information-outside-of-the-us2025-10-14T20:51Zyearly https://www.jazzpharma.com/medicines/medical-information2024-05-13T06:33Zyearly https://www.jazzpharma.com/medicines/our-medicines2026-03-31T22:43Zweekly https://www.jazzpharma.com/about/board-of-directors2025-11-12T21:20Zyearly https://www.jazzpharma.com/our-purpose2024-06-20T16:20Zyearly https://www.jazzpharma.com/our-purpose/corporate-giving2025-10-14T23:23Zyearly https://www.jazzpharma.com/our-purpose/corporate-sustainability-and-social-impact2025-06-27T20:00Zyearly https://www.jazzpharma.com/our-purpose/ethical-standards2026-04-02T20:27Zdaily https://www.jazzpharma.com/our-purpose/fellowships2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/medical-education2026-02-03T22:48Zyearly https://www.jazzpharma.com/our-purpose/patient-resources2026-02-24T21:06Zmonthly https://www.jazzpharma.com/our-purpose/patient-support2025-10-28T21:57Zyearly https://www.jazzpharma.com/about/corporate-development2026-03-31T18:02Zweekly https://www.jazzpharma.com/our-purpose/transfers-of-value2025-08-20T17:04Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/austria-efpia-report-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/disclosure-report-of-ireland-patient-organizations-20172024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/disclosure-report-of-ireland-patient-organizations-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/disclosure-report-of-ireland-patient-organizations-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/disclosure-report-of-switzerland-patient-organizations-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/verfahren-fur-offenlegungen-austria2024-05-11T13:14Zyearly https://www.jazzpharma.com/about/corporate-values2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/verfahren-fur-offenlegungen-austria/austria-2017-disclosure-german2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/verfahren-fur-offenlegungen2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/verfahren-fur-offenlegungen/germany-2017-disclosure-german2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/criteri-informativi2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/criteri-informativi/italy-2017-disclosure-italian2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/metodyka-dotyczaca-ujawnienia-informacji-finansowych2024-05-11T13:14Zyearly https://www.jazzpharma.com/about/history2025-11-25T23:49Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/metodyka-dotyczaca-ujawnienia-informacji-finansowych/poland-2017-disclosure-polish2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/metodologia-de-declaracion2024-05-11T13:14Zyearly https://www.jazzpharma.com/about/leadership2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/metodologia-de-declaracion/spain-2017-disclosure-spanish2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodologie-de-divulgation2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodologie-de-divulgation/switzerland-2017-disclosure2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodology-for-disclosure2024-05-11T13:14Zyearly https://www.jazzpharma.com/about/partnering2025-12-16T21:27Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/germany-efpia-report-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-austria-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-austria-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-austria-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/verfahren-fur-offenlegungen-austria-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-austria-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-finland-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-finland-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-finland-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/about/global-footprint2024-07-31T21:40Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-finland-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-germany-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-germany-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-germany-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-germany-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-germany-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/criteri-informativi-italy-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-italy-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-italy-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-italy-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/about/global-footprint/australia-and-new-zealand2026-02-10T21:26Zmonthly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-italy-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-norway-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-norway-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-norway-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-norway-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/metodyka-dotyczaca-ujawnienia-informacji-finansowych-poland-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-poland-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-poland-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-poland-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-poland-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/about/global-footprint/benelux2025-05-02T21:04Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/metodologia-de-declaracion-spain-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-spain-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-spain-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-spain-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-spain-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-sweden-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-sweden-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-sweden-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-sweden-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-europe-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/about/global-footprint/canada2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-europe-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-europe-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-europe-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodological-note-2021-legacy-gw-hco-hco-report2024-05-11T13:14Zyearly https://www.jazzpharma.com/about/global-footprint/countries-supplied-through-partners2026-03-24T20:02Zweekly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodology-for-disclosure-switzerland-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodology-for-disclosure-switzerland-20192024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodology-for-disclosure-switzerland-20202024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodology-for-disclosure-switzerland-20212024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodology-for-disclosure-switzerland-20222024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/methodology-for-disclosure-switzerland-english2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/poland-efpia-report-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/spain-efpia-report-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/about/global-footprint/france2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/switzerland-efpia-report-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/our-stories2024-05-11T13:14Zyearly https://www.jazzpharma.com/patient-stories2024-05-11T13:40Zyearly https://www.jazzpharma.com/about/global-footprint/germany2025-11-25T21:19Zyearly https://www.jazzpharma.com/about/global-footprint/italy2024-05-11T13:39Zyearly https://www.jazzpharma.com/termsandconditions2024-07-09T19:01Zyearly https://www.jazzpharma.com/science2026-03-31T18:06Zweekly https://www.jazzpharma.com/science/clinical-trial-data-sharing2026-03-31T18:07Zweekly https://www.jazzpharma.com/science/clinical-trials2026-03-31T18:08Zweekly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary2025-06-05T20:27Zyearly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary/14-0022024-05-11T13:14Zyearly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary/14-0032024-05-11T13:14Zyearly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary/14-0042024-05-11T13:14Zyearly https://www.jazzpharma.com/about/global-footprint/nordic-region2025-07-22T20:48Zyearly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary/14-0052024-05-11T13:14Zyearly https://www.jazzpharma.com/science/clinical-trials/gea-trial2024-05-13T15:39Zyearly https://www.jazzpharma.com/science/expanded-access2026-03-31T18:09Zweekly https://www.jazzpharma.com/science/independent-scientific-research2026-03-31T18:10Zweekly https://www.jazzpharma.com/science/non-interventional-studies2024-05-11T13:14Zyearly https://www.jazzpharma.com/science/pipeline2026-02-24T23:00Zmonthly https://www.jazzpharma.com/science-stories2024-05-11T13:36Zyearly https://www.jazzpharma.com/sclc-unbranded-fact-sheet2024-05-11T13:14Zyearly https://www.jazzpharma.com/sitemap2024-05-11T13:14Zyearly https://www.jazzpharma.com/about/global-footprint/spain-and-portugal2024-05-11T13:14Zyearly https://www.jazzpharma.com/social-media-global-guidelines2024-05-11T13:14Zyearly https://www.jazzpharma.com/terms-and-conditions-of-sale2025-05-27T20:42Zyearly https://www.jazzpharma.com/terms-of-use2024-05-11T13:14Zyearly https://www.jazzpharma.com/our-purpose/transfers-of-value/italy-efpia-report-20182024-05-11T13:14Zyearly https://www.jazzpharma.com/science/clinical-trials/plain-language-summary/crest-uk2025-06-05T20:28Zyearly